Centene Corporation (0HVB.L)
USD 59.81
(-0.08%)
USD 59.81
(-0.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 141.26 Billion USD | -2.27% |
| 2022 | 144.54 Billion USD | 14.74% |
| 2021 | 125.98 Billion USD | 13.38% |
| 2020 | 111.11 Billion USD | 48.87% |
| 2019 | 74.63 Billion USD | 24.16% |
| 2018 | 60.11 Billion USD | 24.25% |
| 2017 | 48.38 Billion USD | 19.15% |
| 2016 | 40.6 Billion USD | 78.41% |
| 2015 | 22.76 Billion USD | 45.07% |
| 2014 | 15.68 Billion USD | 48.8% |
| 2013 | 10.54 Billion USD | 36.65% |
| 2012 | 7.71 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 40.4 Billion USD | 2.4% |
| 2024 Q2 | 36.43 Billion USD | -9.83% |
| 2024 Q3 | 42.02 Billion USD | 15.34% |
| 2023 Q3 | 38.04 Billion USD | 1.15% |
| 2023 Q1 | 38.88 Billion USD | 9.36% |
| 2023 FY | 153.99 Billion USD | 6.54% |
| 2023 Q4 | 39.46 Billion USD | 3.73% |
| 2023 Q2 | 37.6 Billion USD | -3.29% |
| 2022 Q2 | 35.93 Billion USD | -3.36% |
| 2022 Q1 | 37.18 Billion USD | 14.18% |
| 2022 Q3 | 35.86 Billion USD | -0.2% |
| 2022 FY | 144.54 Billion USD | 14.74% |
| 2022 Q4 | 35.56 Billion USD | -0.85% |
| 2021 Q3 | 32.4 Billion USD | 4.45% |
| 2021 Q4 | 32.56 Billion USD | 0.5% |
| 2021 FY | 125.98 Billion USD | 13.38% |
| 2021 Q1 | 29.98 Billion USD | 12.93% |
| 2021 Q2 | 31.02 Billion USD | 3.48% |
| 2020 Q2 | 25.83 Billion USD | 6.61% |
| 2020 Q1 | 24.23 Billion USD | 33.61% |
| 2020 Q4 | 26.55 Billion USD | -3.64% |
| 2020 Q3 | 27.55 Billion USD | 6.65% |
| 2020 FY | 111.11 Billion USD | 48.87% |
| 2019 Q2 | 17.41 Billion USD | 2.85% |
| 2019 Q3 | 18.31 Billion USD | 5.13% |
| 2019 FY | 74.63 Billion USD | 24.16% |
| 2019 Q1 | 16.93 Billion USD | 7.77% |
| 2019 Q4 | 18.13 Billion USD | -0.96% |
| 2018 Q2 | 12.94 Billion USD | 2.72% |
| 2018 Q1 | 12.59 Billion USD | 8.17% |
| 2018 Q4 | 15.71 Billion USD | 1.82% |
| 2018 FY | 60.11 Billion USD | 24.25% |
| 2018 Q3 | 15.43 Billion USD | 19.28% |
| 2017 Q4 | 11.64 Billion USD | 1.52% |
| 2017 Q3 | 11.47 Billion USD | -0.12% |
| 2017 Q2 | 11.48 Billion USD | 2.5% |
| 2017 Q1 | 11.2 Billion USD | 4.67% |
| 2017 FY | 48.38 Billion USD | 19.15% |
| 2016 Q4 | 10.7 Billion USD | 4.47% |
| 2016 FY | 40.6 Billion USD | 78.41% |
| 2016 Q3 | 10.24 Billion USD | -0.58% |
| 2016 Q2 | 10.3 Billion USD | 60.41% |
| 2016 Q1 | 6.42 Billion USD | 9.71% |
| 2015 Q2 | 5.19 Billion USD | 8.89% |
| 2015 FY | 22.76 Billion USD | 45.07% |
| 2015 Q1 | 4.77 Billion USD | 7.94% |
| 2015 Q4 | 5.85 Billion USD | 7.06% |
| 2015 Q3 | 5.47 Billion USD | 5.33% |
| 2014 Q2 | 3.74 Billion USD | 11.65% |
| 2014 Q4 | 4.41 Billion USD | 6.1% |
| 2014 Q3 | 4.16 Billion USD | 11.13% |
| 2014 FY | 15.68 Billion USD | 48.8% |
| 2014 Q1 | 3.35 Billion USD | 17.22% |
| 2013 Q1 | 2.42 Billion USD | 38.96% |
| 2013 FY | 10.54 Billion USD | 36.65% |
| 2013 Q3 | 2.73 Billion USD | 8.24% |
| 2013 Q4 | 2.86 Billion USD | 4.87% |
| 2013 Q2 | 2.52 Billion USD | 3.99% |
| 2012 FY | 7.71 Billion USD | 0.0% |
| 2012 Q4 | 1.74 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -39548.161% |
| Accuray Incorporated | 446.55 Million USD | -31534.908% |
| Align Technology, Inc. | 3.86 Billion USD | -3557.599% |
| Elevance Health Inc. | 171.34 Billion USD | 17.552% |
| AxoGen, Inc. | 159.01 Million USD | -88739.836% |
| Boston Scientific Corporation | 14.24 Billion USD | -892.037% |
| CVS Health Corporation | 357.77 Billion USD | 60.516% |
| Cardinal Health, Inc. | 226.82 Billion USD | 37.721% |
| DaVita Inc. | 12.14 Billion USD | -1063.627% |
| HCA Healthcare, Inc. | 64.96 Billion USD | -117.439% |
| Hologic, Inc. | 4.03 Billion USD | -3405.099% |
| Humana Inc. | 106.37 Billion USD | -32.801% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -3758.722% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -1061.574% |
| Masimo Corporation | 2.04 Billion USD | -6797.417% |
| McKesson Corporation | 308.95 Billion USD | 54.276% |
| Patterson Companies, Inc. | 6.56 Billion USD | -2050.733% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -1426.87% |
| ResMed Inc. | 4.68 Billion USD | -2915.092% |
| Henry Schein, Inc. | 12.33 Billion USD | -1044.874% |
| Teladoc Health, Inc. | 2.6 Billion USD | -5328.266% |
| Universal Health Services, Inc. | 14.28 Billion USD | -889.121% |
| Veeva Systems Inc. | 2.36 Billion USD | -5876.546% |
| Baxter International Inc. | 14.81 Billion USD | -853.662% |
| Becton, Dickinson and Company | 19.37 Billion USD | -629.228% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -1882.931% |
| Danaher Corporation | 23.89 Billion USD | -491.319% |
| Stryker Corporation | 20.49 Billion USD | -589.17% |
| Medtronic plc | 32.36 Billion USD | -336.491% |